Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Koreen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Schizophrenia Bulletin|January 1, 1993
Neurochemistry and neuroendocrinology of schizophrenia: a selective reviewJ A Lieberman, A R Koreen
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controlsA R Koreen, J A Lieberman, J Alvir, et al.
The American Journal of Psychiatry|November 1, 1995
Cross-tapering clozapine and risperidoneA R Koreen, J A Lieberman, M Kronig, et al.
The American Journal of Psychiatry|November 1, 1993
Depression in first-episode schizophreniaA R Koreen, S G Siris, M Chakos, et al.
The American Journal of Psychiatry|January 1, 1994
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patientsA R Koreen, J Lieberman, J Alvir, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophreniaJ A Lieberman, A R Koreen, M Chakos, et al.
Archives of General Psychiatry|February 1, 1994
Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment responseA R Koreen, J Lieberman, J Alvir, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Schizophrenia Bulletin|January 1, 1993
Neurochemistry and neuroendocrinology of schizophrenia: a selective reviewJ A Lieberman, A R Koreen
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controlsA R Koreen, J A Lieberman, J Alvir, et al.
The American Journal of Psychiatry|November 1, 1995
Cross-tapering clozapine and risperidoneA R Koreen, J A Lieberman, M Kronig, et al.
The American Journal of Psychiatry|November 1, 1993
Depression in first-episode schizophreniaA R Koreen, S G Siris, M Chakos, et al.
The American Journal of Psychiatry|January 1, 1994
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patientsA R Koreen, J Lieberman, J Alvir, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophreniaJ A Lieberman, A R Koreen, M Chakos, et al.
Archives of General Psychiatry|February 1, 1994
Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment responseA R Koreen, J Lieberman, J Alvir, et al.
Pageof 1